FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

• click to rate

  Posted by Two Blokes Jun 24 - Filed in Stock - 3 views
  
  FDA expands AstraZeneca's Datroway label, making it the first TROP2-directed lung cancer therapy approved in the United States.